Last reviewed · How we verify
Atemorin (methylpentynol)
Atemorin (generic name: methylpentynol) is a methylpentynol drug. It is currently in unknown development for Insomnia.
Atemorin works by affecting the brain's chemistry to promote relaxation and sleep.
Atemorin, also known as methylpentynol, is a small molecule drug in the methylpentynol class. It is used to treat insomnia, a common sleep disorder. The commercial status of Atemorin is currently unknown, and it may be patented or available as a generic medication. As a medication for insomnia, Atemorin's safety considerations include potential side effects and interactions with other medications. Further research is needed to fully understand its pharmacological properties.
At a glance
| Generic name | methylpentynol |
|---|---|
| Drug class | methylpentynol |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is a busy city, and Atemorin helps calm down the traffic by influencing the chemicals that regulate sleep and wakefulness. This allows you to fall asleep and stay asleep more easily. By doing so, Atemorin helps you get the restful sleep you need.
Approved indications
- Insomnia
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atemorin CI brief — competitive landscape report
- Atemorin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Atemorin
What is Atemorin?
How does Atemorin work?
What is Atemorin used for?
What is the generic name of Atemorin?
What drug class is Atemorin in?
What development phase is Atemorin in?
Related
- Drug class: All methylpentynol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Insomnia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing